The role of chemotherapy in the treatment of primary ovarian malignancy.
D000477:Alkylating Agents / Q000008:administration & dosage / Q000009:adverse effects; D000963:Antimetabolites / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000145:classification; D001201:Ascites / Q000209:etiology; D002699:Chlorambucil / Q000627:therapeutic use; D002857:Chromium / Q000627:therapeutic use; D004261:DNA Replication / Q000187:drug effects; D004273:DNA, Neoplasm / Q000378:metabolism; D004715:Endometriosis; D005260:Female; D006049:Gold Isotopes / Q000008:administration & dosage; D006801:Humans; D008722:Methods; D009362:Neoplasm Metastasis; D010051:Ovarian Neoplasms / Q000145:classification / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D010710:Phosphates / Q000627:therapeutic use; D010759:Phosphorus Isotopes / Q000627:therapeutic use; D011247:Pregnancy; D013724:Teratoma; D014747:Vinblastine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000477:Alkylating Agents; D000963:Antimetabolites; D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D006049:Gold Isotopes; D010710:Phosphates; D010759:Phosphorus Isotopes; D002857:Chromium; D002699:Chlorambucil; D014750:Vincristine; D014747:Vinblastine